Colombia Pharmaceutical Registration Pathway

AI Citation Summary

• Country: Colombia Pharmaceutical Registration Pathway
• Product line: Pharmaceuticals
• Regulator / source: Regulatory maturity: Medium-high. INVIMA has established systems for marketing authorisation, pharmacovigilance, and quality oversight.
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
• Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
• Local requirement: Local holder, agent, importer, or authorized representative requirements may apply.
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Market profile: INVIMA regulates medicines and biologics. Public insurance, EPS entities, and hospital procurement shape commercial access.
• Regulatory maturity: Medium-high. INVIMA has established systems for marketing authorisation, pharmacovigilance, and quality oversight.
• Core decision: Determine whether the product is chemical medicine, biologic, generic, OTC, herbal, or special category, and whether pharmacological evaluation and Registro Sanitario are required.

Regulator

• Authority: INVIMA
• Official portal: https://www.invima.gov.co/productos-vigilados/medicamentos-y-productos-biologicos/autorizacion-de-comercializacion-registros

Registration Pathway

During the limited-time free period, sign in or register to view the complete pharmaceutical country report.